This inventor holds 1 USPTO granted patent. Top assignee: The Translational Genomics Research Institute. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Christopher B Heward: Innovator in Alzheimer's Disease Diagnosis
Introduction
Christopher B Heward is a notable inventor based in Mesa, AZ (US). He has made significant contributions to the field of genetics, particularly in the diagnosis of Alzheimer's disease. His work focuses on identifying genetic markers that can aid in the early detection and understanding of this debilitating condition.
Latest Patents
Christopher B Heward holds a patent titled "Methods of diagnosing Alzheimer's disease and markers identified by set association." This patent encompasses a whole-genome association analysis of single nucleotide polymorphisms (SNPs), including several located within the GRB2-associated binding protein 2 (GAB2) gene. The patent identifies two novel haplotypes within the GAB2 gene, which are associated with varying risks of late-onset Alzheimer's disease (LOAD). These haplotypes interact with APOE alleles to modify LOAD risk, and the patent also discusses therapeutic methods and agents aimed at reducing cellular deterioration associated with LOAD. He has 1 patent to his name.
Career Highlights
Christopher B Heward is affiliated with the Translational Genomics Research Institute, where he continues to advance research in genetic markers and their implications for Alzheimer's disease. His innovative approaches have the potential to transform how this disease is diagnosed and treated.
Collaborations
He has collaborated with notable colleagues, including Jennifer Webster and Dietrich A Stephan, contributing to a rich environment of research and innovation.
Conclusion
Christopher B Heward's work in the field of Alzheimer's disease diagnosis exemplifies the impact of genetic research on healthcare. His innovative methods and findings are paving the way for improved diagnostic tools and therapeutic strategies.